Pacific Biosciences of California, Inc.
PACB- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001299130
In the last 90 days, Pacific Biosciences of California, Inc. insiders filed 0 open-market purchases and 1 sale; 223 institutions reported holding it in 13F filings for Q2 2026, worth $320.8M in total; superinvestors ARK Invest and HHLR Advisors (Hillhouse) hold it.
13F holders, Q3 2022
Institutional positions in Pacific Biosciences of California, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 227
- −2 vs. Q2 2022
- Shares held
- 211.8M
- −13.7M (−6.1%) vs. Q2 2022
- Total value
- $1.23B
- +$201.9M (+19.6%) vs. Q2 2022
- New holders
- 39
- 62 more added
- Sold out
- 41
- 70 more reduced
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PACB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 223 | $320.8M |
| Q1 2026 | 231 | $248.5M |
| Q4 2025 | 216 | $373.5M |
| Q3 2025 | 208 | $237.8M |
| Q2 2025 | 207 | $245.8M |
| Q1 2025 | 225 | $265.6M |
| Q4 2024 | 227 | $475.1M |
| Q3 2024 | 226 | $394.3M |
| Q2 2024 | 229 | $331.9M |
| Q1 2024 | 268 | $1.01B |
| Q4 2023 | 274 | $2.76B |
| Q3 2023 | 275 | $2.20B |
| Q2 2023 | 272 | $3.37B |
| Q1 2023 | 260 | $2.93B |
| Q4 2022 | 237 | $1.84B |
| Q3 2022 | 227 | $1.23B |
| Q2 2022 | 230 | $1.03B |
| Q1 2022 | 250 | $2.03B |
| Q4 2021 | 256 | $4.20B |
| Q3 2021 | 246 | $4.83B |
| Q2 2021 | 261 | $6.04B |
| Q1 2021 | 263 | $5.47B |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Pacific Biosciences of California, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Charles Schwab Investment Management Inc | 1,552,107 | $9.01M | 0.00% | −115,772−6.9% | Reduced |
| Norges Bank | 1,697,527 | $9.85M | 0.00% | +448,468+35.9% | Added |
| 12 West Capital Management LP | 1,925,000 | $11.2M | 0.99% | 00.0% | Unchanged |
| Deerfield Management Company, L.P. (Series C) | 2,021,000 | $11.7M | 0.23% | +2,021,000 | New |
| Northern Trust Corp | 2,414,076 | $14.0M | 0.00% | +294,991+13.9% | Added |
| Point72 Asset Management, L.P. | 2,534,106 | $14.7M | 0.06% | +2,534,106 | New |
| Morgan Stanley | 2,574,880 | $14.9M | 0.00% | −641,686−19.9% | Reduced |
| Iron Triangle Partners LP | 3,000,000 | $17.4M | 3.04% | +3,000,000 | New |
| Price T Rowe Associates Inc | 3,370,628 | $19.6M | 0.00% | −6,913,462−67.2% | Reduced |
| Capital World Investors | 3,390,000 | $19.7M | 0.00% | 00.0% | Unchanged |
| SEI Investments Co | 3,493,262 | $20.3M | 0.05% | −356,287−9.3% | Reduced |
| Goldman Sachs Group Inc | 3,655,445 | $21.2M | 0.01% | −4,783,127−56.7% | Reduced |
| Macquarie Group Ltd | 4,023,272 | $23.4M | 0.03% | +48,995+1.2% | Added |
| Geode Capital Management, LLC | 4,028,938 | $23.4M | 0.00% | −54,359−1.3% | Reduced |
| Citadel Advisors LLC | 4,935,112 | $28.6M | 0.04% | +4,619,581+1,464.1% | Added |
| State Street Corp | 5,051,353 | $29.3M | 0.00% | +710,784+16.4% | Added |
| Bellevue Group AG | 5,439,551 | $31.6M | 0.45% | −521,678−8.8% | Reduced |
| T. Rowe Price Investment Management, Inc. | 7,572,558 | $44.0M | 0.04% | +7,572,558 | New |
| Capital International Investors | 8,449,158 | $49.0M | 0.01% | −3,126,338−27.0% | Reduced |
| Sumitomo Mitsui Trust Holdings, Inc. | 14,391,962 | $83.5M | 0.07% | +46,477+0.3% | Added |
| Nikko Asset Management Americas, Inc. | 14,391,962 | $84.5M | 1.08% | +46,477+0.3% | Added |
| BlackRock Inc. | 17,908,556 | $104.0M | 0.00% | −473,105−2.6% | Reduced |
| Vanguard Group Inc | 19,662,066 | $114.1M | 0.00% | −1,579,252−7.4% | Reduced |
| Jackson Square Partners, LLC | 20,258,099 | $117.6M | 3.08% | −2,503,943−11.0% | Reduced |
| ARK Investment Management LLCSuperinvestorARK Invest | 28,692,494 | $166.6M | 1.16% | +646,964+2.3% | Added |
| Federated Hermes, Inc. | 1 | – | – | −4,608−100.0% | Reduced |
| Sofos Investments, Inc. | 12 | – | – | +4+50.0% | Added |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −4,487,462−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −493,119−100.0% | Sold out |
| Camber Capital Management LP | 0 | $0 | 0.00% | −424,600−100.0% | Sold out |
| California Public Employees Retirement System | 0 | $0 | 0.00% | −307,737−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −230,813−100.0% | Sold out |
| Voloridge Investment Management, LLC | 0 | $0 | 0.00% | −220,926−100.0% | Sold out |
| Mass Ave Global Inc. | 0 | $0 | 0.00% | −165,844−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −151,259−100.0% | Sold out |
| Graham Capital Management, L.P. | 0 | $0 | 0.00% | −134,862−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −114,200−100.0% | Sold out |
| HSBC Holdings PLC | 0 | $0 | 0.00% | −95,454−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −65,583−100.0% | Sold out |
| Parametrica Management Ltd | 0 | $0 | 0.00% | −54,497−100.0% | Sold out |
| Water Island Capital LLC | 0 | $0 | 0.00% | −44,549−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −39,185−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −38,385−100.0% | Sold out |
| Algert Global LLC | 0 | $0 | 0.00% | −33,340−100.0% | Sold out |
| Profund Advisors LLC | 0 | $0 | 0.00% | −30,448−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −29,436−100.0% | Sold out |
| Old National Bancorp | 0 | $0 | 0.00% | −25,613−100.0% | Sold out |
| Moors & Cabot, Inc. | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | – | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −15,700−100.0% | Sold out |
| Carnegie Capital Asset Management, LLC | 0 | $0 | 0.00% | −14,250−100.0% | Sold out |
| Fox Run Management, L.L.C. | 0 | $0 | 0.00% | −14,173−100.0% | Sold out |
| Foundations Investment Advisors, LLC | 0 | $0 | 0.00% | −10,441−100.0% | Sold out |
| Vontobel Holding Ltd. | 0 | $0 | 0.00% | −10,362−100.0% | Sold out |
| Interchange Capital Partners, LLC | 0 | $0 | 0.00% | −10,506−100.0% | Sold out |
| Versor Investments LP | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Ford Foundation | 0 | $0 | 0.00% | −9,394−100.0% | Sold out |
| Smithfield Trust Co | 0 | $0 | 0.00% | −4,862−100.0% | Sold out |
| Hexagon Capital Partners LLC | 0 | $0 | 0.00% | −3,000−100.0% | Sold out |
| Gables Capital Management Inc. | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −1,553−100.0% | Sold out |
| Prospera Financial Services Inc | 0 | $0 | 0.00% | −663−100.0% | Sold out |
| State of Wyoming | 0 | $0 | 0.00% | −463−100.0% | Sold out |
| Geneos Wealth Management Inc. | 0 | $0 | 0.00% | −240−100.0% | Sold out |
| Global Wealth Management Investment Advisory, Inc. | 0 | $0 | 0.00% | −135−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| Ellevest, Inc. | 0 | $0 | 0.00% | −70−100.0% | Sold out |
| Concord Wealth Partners | 0 | $0 | 0.00% | −93−100.0% | Sold out |
| Brewin Dolphin Wealth Management Ltd | – | – | – | – | Not filed |